Clear Street’s Novo Nordisk NVO Stock Holding History

Clear Street’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$10.9M	Sell	297,061 -283,765	-49%	-$13.4M	0.04%	97
2025 Q4	$29.6M	Sell	580,826 -435,174	-43%	-$22.3M	0.11%	69
2025 Q3	$56.4M	Buy	+1,016,000	New	+$59.5M	0.19%	54
2023 Q3	–	Sell	-79,600	Closed	-$6.44M	–	1240
2023 Q2	$6.44M	Buy	+79,600	New	+$6.5M	0.06%	164

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Clear Street's NVO Position: Q1 2026 in Review

Clear Street reduced its Novo Nordisk (NVO) stake by 49% in Q1 2026, selling an estimated $13.4M and leaving 297,061 shares worth $10.9M. The position accounts for 0.04% of the portfolio, ranked #97.

Clear Street first reported a position in NVO in Q2 2023 and has held it in 4 quarters since. The position peaked at $56.4M in Q3 2025. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Clear Street held 297,061 shares of Novo Nordisk worth $10.9M as of Q1 2026.
Clear Street sold 283,765 Novo Nordisk shares in Q1 2026, an estimated $13.4M.
Novo Nordisk made up 0.04% of Clear Street's portfolio in Q1 2026, its #97 holding.
Clear Street first reported a position in Novo Nordisk in Q2 2023 and has held it in 4 quarters since.
Clear Street's Novo Nordisk position peaked at $56.4M in Q3 2025.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Clear Street's 13F filing for Q1 2026, filed 15 May 2026.